Humanigen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.22	HGEN DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL Encourages Humanigen, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Tuesday Deadline in Securities Class Act... (PR Newswire)
18.10.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGEN (PR Newswire)
08.10.22	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
30.09.22	ROSEN, A TOP RANKED FIRM, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
18.09.22	ROSEN, A LEADING LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
12.09.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
06.09.22	ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
31.08.22	HGEN INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Humanigen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN (PR Newswire)
13.07.22	Humanigen: Lenzilumab Combination Trial In Hospitalized COVID-19 Patients Fails To Meet Main Goal (RTTNews)
12.05.22	Pre-market Movers: BROS, SLS, DTST, BYND, CISO… (RTTNews)
10.02.22	Humanigen's Antibody Lenzilumab Available Through Managed Access Program For Covid-19 Patients (RTTNews)
09.02.22	Humanigen Joins Hands With Cenexi To Make Lenzilumab In France (RTTNews)
10.09.21	MÄRKTE USA/Inflationsängste bremsen Börsen - Apple belasten Dow (Dow Jones)
09.09.21	Pre-market Movers: HGEN, PMCB, CRDF, HLBZ, LULU… (RTTNews)
09.07.21	Humanigen Says Marketing Authorization Submission For Lenzilumab Accepted In UK For Covid Treatment (RTTNews)
28.05.21	Humanigen Submits EUA Application To FDA For Lenzilumab In COVID-19 - Quick Facts (RTTNews)
29.03.21	Humanigen: Lenzilumab Improves Survival Without Need For Mechanical Ventilation In COVID-19 Patients (RTTNews)
22.01.21	Stock Alert: Humanigen Trading 5% Higher (RTTNews)
10.01.21	Humanigen, EVERSANA Announce Partnership To Support The Launch Of Lenzilumab For COVID-19 (RTTNews)
06.11.20	Humanigen Reports Positive Interim Phase 3 Data Of Lenzilumab In Treatment Of COVID-19 (RTTNews)
14.10.20	Pre-market Movers In Healthcare Sector: MDRX, TLC, HGEN, ENLV, BNTX, ATEC... (RTTNews)
07.10.20	AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track (RTTNews)
06.10.20	GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch (RTTNews)
23.09.20	Humanigen Collaborates With Thermo Fisher To Expand Manufacturing Capacity For Lenzilumab (RTTNews)
22.09.20	ABIO Joins Battle Against COVID-19, ERYP On Watch, LPCN To Report NASH Study Results In Q1 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Humanigen Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten